Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed Sofinnova Capital XI at €650 million ($750 million) — well above its initial target.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?